Jsmc-10376

CONSISTENCY BETWEEN BRONCHOALVEOLAR LAVAGE AND ENDOTRACHEAL ASPIRATE IN THE DIAGNOSIS OF VENTILATOR-ASSOCIATED PNEUMONIA

Kamaran Omer Amin a, Bnar J. Hama Amin b, Haval Othman b, Safeen Othman Mahmood b, Nsar Jamal Abdalla b, and Kosar Mohamed Ali a

a College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. 

b Shar Teaching Hospital, Sulaimani City, Kurdistan Region, Iraq.

Submitted: 27/5/2022; Accepted: 21/10/2022; Published: 21/12/2022

DOI Link: https://doi.org/10.17656/jsmc.10376 

ABSTRACT 

Background 

Ventilator-associated pneumonia (VAP) is a common nosocomial lung infection. Quick and accurate identification of the causative pathogen is crucial to improve prognosis. To date, the literature is controversial regarding whether endotracheal aspirate (ETA) can be used as an alternative to bronchoalveolar lavage (BAL) in VAP diagnosis.

Objectives 

To evaluate the consistency between the results of BAL and ETA in the diagnosis of early- and late VAP and to determine the microbial profiles of the involved microorganisms and their antimicrobial susceptibility. 

Patients and Methods

This is a single-centre prospective study that included 50 VAP-suspected patients conducted at Shar Hospital, Sulaimani, Iraq, from July 2021 to February 2022. The patients were categorised into early VAP and late VAP. For each patient, both ETA and BAL techniques were used to obtain samples for microbiological analysis and antimicrobial susceptibility testing.

Results

Ten (20%) patients developed early VAP, and 40 (80%) developed late VAP. The culture results of samples obtained by BAL showed microbial growth in 45 (90%) of the cases. Meanwhile, ETA resulted in microbial growth in 40 (80%) patients. In 45 (90%) of the samples, both techniques yielded the same results regarding microbial growth in the cultures. Among the 45 samples with the same growth results, 35 (70%) showed the same type of microbes, and 5 (10%) showed no microbial growth, indicating substantial agreement. In both BAL and ETA, Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii were the most frequently isolated pathogens. Both early- and late-VAP were associated with a high frequency of multidrug-resistant microorganisms, 6 (75%) and 25 (56.8%), respectively. However, extensively drug-resistant/pan-drug-resistant isolates were much more common in late-VAP patients (12, 27.3%). 

Conclusion

ETA can be a reliable, non-invasive alternative to BAL in VAP diagnosis associated with rapid and relatively accurate results.

KEYWORDS

Ventilator-associated pneumonia; endotracheal aspirate; comparison; bronchoalveolar lavage; antimicrobial susceptibility screening

References 

1. Alqurashi AM. Antibiotic susceptibility patterns of different bacteria isolated from ventilator-associated pneumoniae (VAP) patients. Journal of Family & Community Medicine. 2005; 12(3):139-44.

2. Krishnamurthy V, Vijay Kumar GS, Prashanth HV, Prakash R, Kumar MS. Ventilator-associated pneumonia: bacterial isolates and its antibiotic resistance pattern. Int J Biol Med Res. 2013; 4(2):3135–8.

3. Pradhan R, Singh S, Modi C, Khandelwal V, Agrawal R. Antimicrobial Susceptibility Pattern of Isolates from Cases Of Ventilator Associated Pneumonia (VAP) In Medical And Surgical Intensive Care Units. National Journal of Integrated Research in Medicine. 2017; 8(1):48-53.

4. Canadian Critical Care Trials Group. A randomised trial of diagnostic techniques for ventilator-associated pneumonia. New England Journal of Medicine. 2006; 355(25):2619-30.

5. Ahmadinejad M, Mohammadzadeh S, Pak H, Hashemiyazdi S, Soltanian A, Rahimi M, et al. Bronchoalveolar lavage of ventilator-associated pneumonia patients for antibiotic resistance and susceptibility test. Health Science Reports. 2022; 5(1):e472.

6. Gupta V, Singla N, Gombar S, Palta S, Chander J. Prevalence of multidrug-resistant pathogens and their antibiotic susceptibility pattern from late-onset ventilator-associated pneumonia patients from a tertiary-care hospital in North India. The Journal of Association of Chest Physicians. 2018; 6(1):4-11.

7. Ben Lakhal H, M’Rad A, Naas T, Brahmi N. Antimicrobial Susceptibility among Pathogens Isolated in Early-versus Late-Onset Ventilator-Associated Pneumonia. Infectious disease reports. 2021; 13(2):401-10.

8. Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, et al. diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Critical care. 2008; 12(2):1-4.

9. Fernando SM, Tran A, Cheng W, Klompas M, Kyeremanteng K, Mehta S, et al. diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis. Intensive care medicine. 2020; 46(6):1170-9.

10. Sharvani R, Usha MG. Bacteriological Profile of Ventilator-Associated Pneumonia (VAP) and Their Antibiotic Susceptibility-A Prospective Study. Journal of Pure and Applied Microbiology. 2017; 11(3):1517-21.

11. Carvalho MV, Winkeler GF, Costa FA, Bandeira TD, Pereira ED, Holanda MA. Concordance between tracheal aspirate and bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Jornal Brasileiro de Pneumologia. 2004; 30(1):26-38.

12. MacVane SH, Oppermann N, Humphries RM. Time to result for pathogen identification and antimicrobial susceptibility testing of bronchoalveolar lavage and endotracheal aspirate specimens in US acute care hospitals. Journal of clinical microbiology. 2020; 58(11):e01468-20.

13. Asty H, Loesnihari R, Syarani F. Detection of Bacteria Causes Ventilator Associated Pneumonia with Bronchoalveolar Lavage Culture and Endotracheal Aspirate Culture. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2019; 26(1):40-5.

14. Yagmurdur H, Tezcan AH, Karakurt O, Leblebici F. The efficiency of routine endotracheal aspirate cultures compared to bronchoalveolar lavage cultures in ventilator-associated pneumonia diagnosis. Nigerian journal of clinical practice. 2016; 19(1):46-51.

15. Mondi MM, Chang MC, Bowton DL, Kilgo PD, Meredith JW, Miller PR. Prospective comparison of bronchoalveolar lavage and quantitative deep tracheal aspirate in the diagnosis of ventilator-associated pneumoniae. Journal of Trauma and Acute Care Surgery. 2005; 59(4):891-6.

16. Fernández-Barat L, Motos A, Ranzani OT, Bassi GL, Aguilera Xiol E, Senussi T, et al. Diagnostic value of endotracheal aspirates sonication on ventilator-associated pneumonia microbiologic diagnosis. Microorganisms. 2017; 5(3):62.

17. Chastre J, Fagon JY. Ventilator-associated pneumonia. American journal of respiratory and critical care medicine. 2002; 165(7):867-903.

18. Shafi M, Ahmed S, Athar M, Ali S, Doley K, Bano S. Correlation between tracheal aspirate culture and bronchoalveolar lavage culture for the diagnosis of ventilator-associated pneumoniae. Int J Curr Microbiol App Sci. 2015; 1(1):143–9.

19. Cook D, Mandell L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest. 2000; 117(4):195S-7S.

20. Lambert RS, Vereen LE, George RB. Comparison of tracheal aspirates and protected brush catheter specimens for identifying pathogenic bacteria in mechanically ventilated patients. The American journal of the medical sciences. 1989; 297(6):377-82.

21. Morris AC, Kefala K, Simpson AJ, Wilkinson TS, Everingham K, Kerslake D, et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax. 2009; 64(6):516-22.

22. Andrews CP, Coalson JJ, Smith JD, Johanson WG. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 1981; 80(3):254-8.

23. Fagon JY, Chastre J, Hance AJ, Guiguet M, Trouillet JL, Domart Y, et al. Detection of nosocomial lung infection in ventilated patients. Am Rev Respir Dis. 1988; 138(1):110.

24. Scholte JB, van Dessel HA, Linssen CF, Bergmans DC, Savelkoul PH, Roekaerts PM, et al. Endotracheal aspirate and bronchoalveolar lavage fluid analysis: interchangeable diagnostic modalities in suspected ventilator-associated pneumonia? Journal of clinical microbiology. 2014; 52(10):3597-604.

25. Fagan J, Chastre J, Wolff M. Invasive and non-invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med. 2000; 132(8):612–30.

26. Hayashi Y, Morisawa K, Klompas M, Jones M, Bandeshe H, Boots R, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clinical infectious diseases. 2013; 56(4):471-7.

27. Azzab MM, El Sokkary RH, Tawfeek MM, Gebriel MG. Multidrug-resistant bacteria among patients with ventilator-associated pneumonia in an emergency intensive care unit, Egypt. EMHJ-Eastern Mediterranean Health Journal. 2016; 22(12):894-903.

28. Djordjevic ZM, Folic MM, Jankovic SM. Distribution and antibiotic susceptibility of pathogens isolated from adults with hospital-acquired and ventilator-associated pneumonia in the intensive care unit. Journal of infection and public health. 2017; 10(6):740-4.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.